Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 0
+0.88%+6.38%+76.40%+126.87% 1,11900Cr
+1.07%+3.80%+50.73%+64.25% 65TCr
+1.20%+6.21%+25.81%+80.15% 47TCr
+1.02%+5.77%+43.63%+43.06% 37TCr
+0.85%+4.07%+24.97%+41.00% 30TCr
+1.26%+6.81%+2.27%+13.65% 26TCr
+1.88%+5.81%+49.57%+70.71% 24TCr
+1.59%+2.09%-17.33%-53.85% 21TCr
+1.87%+5.61%+27.32%+89.67% 18TCr
Average +1.16%+5.17%+31.49%+52.83% 42.22TCr
Weighted average by Cap. +1.14%+5.40%+44.26%+72.42%
Logo Shire
Shire specializes in developing, producing, and marketing pharmaceutical products for the treatment of nervous system dysfunctions (hyperactivity, epilepsy, Alzheimer's disease, etc.), cancer, gastro-intestinal illnesses, and infectious diseases. Net sales break down by source of income as follows: - sales of products (95.3%); - other (4.7%): primarily franchise royalties. Net sales break down geographically as follows: the United States (63.6%), Ireland (0.4%) and other (36%).
Employees
-